Login
Home
Charts
Search
Watchlist
Products

NACL Industries Ltd

NACLIND·NSE
139.23+0.44%Wed, 23 Sept '26 15:55

NACL Industries Ltd

NACLIND
NSE
139.23
+0.44%
|Wed, 23 Sept '26 15:55
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,267Cr
Close
Close Price
139.49
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
284.67
PS
Price To Sales
2.15
Revenue
Revenue
1,519Cr
Rev Gr TTM
Revenue Growth TTM
11.90%
PAT Gr TTM
PAT Growth TTM
121.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
580365457325440268201448457318361383
Growth YoY
Revenue Growth YoY%
2.7-23.9-23.6-13.5-24.1-26.7-55.938.03.818.879.2-14.5
Expenses
ExpensesCr
550361446329400294275410412312348342
Operating Profit
Operating ProfitCr
31411-441-26-74384571341
OPM
OPM%
5.31.12.4-1.19.3-9.8-36.78.59.82.13.710.8
Other Income
Other IncomeCr
114242301-17022
Interest Expense
Interest ExpenseCr
2019191817151414131276
Depreciation
DepreciationCr
777777878899
PBT
PBTCr
6-20-11-2720-47-66186-14-128
Tax
TaxCr
2-4-2-65-10-1654-307
PAT
PATCr
4-16-9-2115-36-50133-10-121
Growth YoY
PAT Growth YoY%
-86.3-196.2-126.945.4265.2-127.9-454.9162.7-82.972.098.359.8
NPM
NPM%
0.7-4.3-2.0-6.43.4-13.5-24.82.90.6-3.2-0.25.4
EPS
EPS
0.2-0.7-0.4-0.90.7-1.7-2.30.60.1-0.50.00.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
580365457325440268201448457318361383
Growth YoY
Revenue Growth YoY%
2.7-23.9-23.6-13.5-24.1-26.7-55.938.03.818.879.2-14.5
Expenses
ExpensesCr
550361446329400294275410412312348342
Operating Profit
Operating ProfitCr
31411-441-26-74384571341
OPM
OPM%
5.31.12.4-1.19.3-9.8-36.78.59.82.13.710.8
Other Income
Other IncomeCr
114242301-17022
Interest Expense
Interest ExpenseCr
2019191817151414131276
Depreciation
DepreciationCr
777777878899
PBT
PBTCr
6-20-11-2720-47-66186-14-128
Tax
TaxCr
2-4-2-65-10-1654-307
PAT
PATCr
4-16-9-2115-36-50133-10-121
Growth YoY
PAT Growth YoY%
-86.3-196.2-126.945.4265.2-127.9-454.9162.7-82.972.098.359.8
NPM
NPM%
0.7-4.3-2.0-6.43.4-13.5-24.82.90.6-3.2-0.25.4
EPS
EPS
0.2-0.7-0.4-0.90.7-1.7-2.30.60.1-0.50.00.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6927358478651,0151,1911,6332,1161,7791,2351,5841,519
Growth
Revenue Growth%
-7.26.215.22.217.317.437.129.5-15.9-30.628.411.9
Expenses
ExpensesCr
6366797988529461,0791,4931,9231,7621,2971,4821,413
Operating Profit
Operating ProfitCr
565649146911314119317-63103106
OPM
OPM%
8.17.65.71.66.89.58.69.11.0-5.16.57.0
Other Income
Other IncomeCr
1941202781511111038-15-14
Interest Expense
Interest ExpenseCr
373833342928274776654639
Depreciation
DepreciationCr
272820202425252827293233
PBT
PBTCr
113115-132475100128-76-1191020
Tax
TaxCr
2-14-77242634-17-2758
PAT
PATCr
93212-717517395-59-92512
Growth
PAT Growth%
16.1258.5-63.4-160.1340.9204.644.029.2-162.1-56.4105.0121.2
NPM
NPM%
1.34.31.4-0.81.64.34.54.5-3.3-7.50.30.8
EPS
EPS
0.61.90.7-0.40.92.43.44.4-2.7-4.20.20.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6927358478651,0151,1911,6332,1161,7791,2351,5841,519
Growth
Revenue Growth%
-7.26.215.22.217.317.437.129.5-15.9-30.628.411.9
Expenses
ExpensesCr
6366797988529461,0791,4931,9231,7621,2971,4821,413
Operating Profit
Operating ProfitCr
565649146911314119317-63103106
OPM
OPM%
8.17.65.71.66.89.58.69.11.0-5.16.57.0
Other Income
Other IncomeCr
1941202781511111038-15-14
Interest Expense
Interest ExpenseCr
373833342928274776654639
Depreciation
DepreciationCr
272820202425252827293233
PBT
PBTCr
113115-132475100128-76-1191020
Tax
TaxCr
2-14-77242634-17-2758
PAT
PATCr
93212-717517395-59-92512
Growth
PAT Growth%
16.1258.5-63.4-160.1340.9204.644.029.2-162.1-56.4105.0121.2
NPM
NPM%
1.34.31.4-0.81.64.34.54.5-3.3-7.50.30.8
EPS
EPS
0.61.90.7-0.40.92.43.44.4-2.7-4.20.20.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1616161719202020202023
Reserves
ReservesCr
170213223247338397469554491407660
Current Liabilities
Current LiabilitiesCr
3563684324315534538311,1151,143687647
Non Current Liabilities
Non Current LiabilitiesCr
695342274410419622616410934
Total Liabilities
Total LiabilitiesCr
6116517137429559761,5161,9151,8181,2231,364
Current Assets
Current AssetsCr
4164625305556916931,1301,4121,288666825
Non Current Assets
Non Current AssetsCr
195189183188264283385504530557539
Total Assets
Total AssetsCr
6116517137429559761,5161,9151,8181,2231,364
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1616161719202020202023
Reserves
ReservesCr
170213223247338397469554491407660
Current Liabilities
Current LiabilitiesCr
3563684324315534538311,1151,143687647
Non Current Liabilities
Non Current LiabilitiesCr
695342274410419622616410934
Total Liabilities
Total LiabilitiesCr
6116517137429559761,5161,9151,8181,2231,364
Current Assets
Current AssetsCr
4164625305556916931,1301,4121,288666825
Non Current Assets
Non Current AssetsCr
195189183188264283385504530557539
Total Assets
Total AssetsCr
6116517137429559761,5161,9151,8181,2231,364

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4658243610383-124-2050469-104
Investing Cash Flow
Investing Cash FlowCr
-12-6-14-27-9714-163-142-384-58
Financing Cash Flow
Financing Cash FlowCr
-33-58-11-970-113290135-22-448108
Net Cash Flow
Net Cash FlowCr
1-5-1077-162-28-925-55
Free Cash Flow
Free Cash FlowCr
3463253710383-124-2011438-134
CFO To PAT
CFO To PAT%
517.4184.8211.6-523.9615.5163.5-169.3-21.5-85.6-509.0-2,278.8
CFO To EBITDA
CFO To EBITDA%
81.6104.450.4264.8150.274.0-88.3-10.6296.1-746.0-101.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4658243610383-124-2050469-104
Investing Cash Flow
Investing Cash FlowCr
-12-6-14-27-9714-163-142-384-58
Financing Cash Flow
Financing Cash FlowCr
-33-58-11-970-113290135-22-448108
Net Cash Flow
Net Cash FlowCr
1-5-1077-162-28-925-55
Free Cash Flow
Free Cash FlowCr
3463253710383-124-2011438-134
CFO To PAT
CFO To PAT%
517.4184.8211.6-523.9615.5163.5-169.3-21.5-85.6-509.0-2,278.8
CFO To EBITDA
CFO To EBITDA%
81.6104.450.4264.8150.274.0-88.3-10.6296.1-746.0-101.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3094386175014307461,6111,6271,1262,0482,9133,267
Price To Earnings
Price To Earnings
31.913.453.425.614.622.017.1622.0284.7
Price To Sales
Price To Sales
0.50.60.70.60.40.61.00.80.61.71.82.1
Price To Book
Price To Book
1.71.92.61.91.21.83.32.82.24.84.34.8
EV To EBITDA
EV To EBITDA
9.111.217.049.98.37.714.511.8108.6-38.031.034.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.631.327.022.723.625.120.719.916.820.726.526.5
OPM
OPM%
8.17.65.71.66.89.58.69.11.0-5.16.57.0
NPM
NPM%
1.34.31.4-0.81.64.34.54.5-3.3-7.50.30.8
ROCE
ROCE%
11.916.010.74.48.716.612.413.50.0-6.65.65.6
ROE
ROE%
4.813.84.8-2.64.712.215.016.5-11.5-21.60.70.7
ROA
ROA%
1.44.91.6-0.91.85.24.85.0-3.2-7.50.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3094386175014307461,6111,6271,1262,0482,9133,267
Price To Earnings
Price To Earnings
31.913.453.425.614.622.017.1622.0284.7
Price To Sales
Price To Sales
0.50.60.70.60.40.61.00.80.61.71.82.1
Price To Book
Price To Book
1.71.92.61.91.21.83.32.82.24.84.34.8
EV To EBITDA
EV To EBITDA
9.111.217.049.98.37.714.511.8108.6-38.031.034.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.631.327.022.723.625.120.719.916.820.726.526.5
OPM
OPM%
8.17.65.71.66.89.58.69.11.0-5.16.57.0
NPM
NPM%
1.34.31.4-0.81.64.34.54.5-3.3-7.50.30.8
ROCE
ROCE%
11.916.010.74.48.716.612.413.50.0-6.65.65.6
ROE
ROE%
4.813.84.8-2.64.712.215.016.5-11.5-21.60.70.7
ROA
ROA%
1.44.91.6-0.91.85.24.85.0-3.2-7.50.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
NACL Industries is a crop protection company that has spent three decades evolving from a single-molecule manufacturer into an integrated partner for both farmers and multinational chemical giants - and in FY26, it became a subsidiary of Coromandel International, part of the 125-year-old Murugappa Group. Founded in 1993 to make the insecticide Monocrotophos, the company now develops, manufactures and sells everything from the raw active ingredient to the branded bottle on a dealer’s shelf, serving roughly 5 million farmers across 39 countries. The recurring approach is to build deep, long-term manufacturing relationships - some spanning over 20 years - with large MNCs, and then use that technical credibility and scale to fuel a branded retail business at home and a growing export footprint abroad. # Business segments A single integrated engine - crop protection chemicals - run through three complementary channels that share the same factories, R&D and registrations: contract manufacturing for global MNCs, branded retail to Indian farmers, and exports to 39 countries. ## 1. Contract manufacturing: the technical backbone and the MNC trust engine **Making active ingredients and intermediates for the world’s largest agrochemical companies, on multi-decade contracts, provides the scale, technical rigour and steady demand that the rest of the business is built on.** - **MNC relationships older than most startups** - the company describes its contract manufacturing ties with large multinationals as spanning over two decades, built on technical precision and consistent delivery, with some products made exclusively for a single customer. - **Scale that negotiates for itself** - the B2B business serves over 163 institutional customers with a portfolio of more than 10 products, and the company believes its volume lets it secure favourable terms from over 30 raw-material vendors across China, the US and elsewhere. - **A buffer against the weather** - because institutional orders are less tied to a single monsoon season than farmer purchases, the B2B book diversifies the customer base and smooths out the seasonal swings inherent in Indian agriculture. - **R&D that pays its own bills** - the company’s GLP-accredited lab not only supports internal process development but also sells studies like impurity profiling and method validation to external clients, turning a cost centre into a revenue stream. ## 2. Domestic branded retail: the farmer-facing engine **A portfolio of over 66 branded insecticides, fungicides, herbicides and plant-growth regulators sold through more than 6,500 dealers, backed by village-level demonstrations and digital tools that pull product through the channel.** - **Direct reach, not just wholesale push** - the company uses a direct-to-retail model with stock depots and a dedicated sales force, and it runs farmer outreach programmes including field demonstrations and village meetings to build brand pull at the ground level. - **A brand for every major crop and pest** - the portfolio covers rice, cotton, soybean, maize, wheat, sugarcane, onion, tea and vegetables, with flagship names like Profex Super (insecticide). - **Credit and inventory are part of the product** - because farming is seasonal and monsoon-dependent, the company routinely carries receivables of 130-140 days and holds around 90 days of inventory to ensure product is on the shelf when the pest pressure hits. - **Digital glue for a physical network** - a WhatsApp bot for dealers, Power BI dashboards and the Krishi Kalyan app give farmers and sales teams instant access to pest identification, dosage recommendations and procurement workflows. ## 3. International business: the registration-led export engine **Exports of technicals and branded formulations to 39 countries, built on 147 overseas registrations and a key-accounts model that supplies active ingredients to global MNCs.** - **Two distinct export lanes** - one is a Key Accounts business selling active ingredients directly to large MNCs worldwide; the other is a portfolio of generic and differentiated formulations sold through national importers in Asia, Africa and Latin America. - **The Americas anchor the book** - the Americas have historically been the largest export region, contributing 62% of export sales in some periods, with destinations also spanning Japan, Brazil, Europe, Southeast Asia and Africa. - **Growing despite a shrinking global market** - export revenues grew 14% in FY26 even as the global crop protection industry contracted roughly 7% to USD 77 billion and India’s agrochemical exports dipped 3%. # Manufacturing and R&D: the shared capability engine **Four plants and a GLP-accredited R&D centre form a single integrated production backbone that serves all three channels - contract manufacturing, domestic retail and exports - from the same assets.** - **Three chemistries, one campus** - the 76-acre Srikakulam plant in Andhra Pradesh makes technical-grade insecticides, fungicides and herbicides with an installed capacity of 13,000 tonnes per annum, and is cleared to expand to 70.1 tonnes per day. - **Formulations at scale** - the Ethakota unit houses two dedicated formulation plants that can handle 12,000 kilolitres of liquids, 5,600 tonnes of powders and 35,475 tonnes of granules, with a packaging facility that turns bulk into branded bottles and bags. - **Speciality chemicals via a subsidiary** - the Dahej plant in Gujarat, operated through NACL Spec-Chem Limited, adds 6,000 tonnes per annum of speciality chemicals capacity and began commercial production in December 2022. - **Zero liquid discharge as a licence to operate** - the Srikakulam ZLD plant, commissioned in 2010 at a cost of ₹30 crore, recycles all process water and meets nearly half the site’s water needs through reuse, while continuous online emissions monitoring is integrated directly with Pollution Control Board servers. - **R&D with OECD credentials** - the Hyderabad-area R&D centre holds GLP accreditation recognised by all OECD countries, meaning its test data is accepted by regulators in the US, Canada, Australia, Japan, the UK and Germany without re-testing. # Group structure and partners **NACL is now a 53.73% subsidiary of Coromandel International, part of the Murugappa Group, giving it a parent with a balance sheet and distribution heft in Indian agriculture - while its own subsidiary web runs speciality chemicals, multi-crop nutrients and a greenfield expansion.** - **A subsidiary cluster for new chemistries** - wholly owned NACL Spec-Chem runs the Dahej speciality chemicals plant, while NACL Multichem is building a 38,000-tonne-per-annum greenfield agrochemicals project at Srikakulam and NACL Agri-Solutions markets advanced micronutrient formulations like Zinc Oxide SC and Boron Ethanolamine. - **Co-marketing with Japanese partners** - since 2016, the company has had a partnership with leading Japanese chemical companies for the herbicide Sirius and the plant growth regulator Atonik, combining NACL’s Indian distribution with their proprietary molecules. - **Foreign subsidiaries wound down** - the Board approved the closure of the Australian and Nigerian subsidiaries in May 2026, after they had served their purpose of holding local product registrations.

Documents — NACL Industries Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/1b58fpx8jjcqbtgv643ys8wf.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/dc9zyseo49iv2z8ig6a61num.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/nyxy5juk1qjzfzxposdjci9n.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/j4veqe8564h2ocq6caph32uh.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/qykh9pko7vbrbsmwyle13v32.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/yk8ozg8rye56uvs6ywm9651a.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/w7t8j9mwuq4xnri8w89w9zcd.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/k15lobdb5w1wqr65yj76upt8.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/rc8i7vlog6l1b1tc5u5c85ow.pdf
  • Q1 FY2024 Investor Presentation (Jun 2023, PDF): https://www.stockscans.in/document/ollc9nqd27zezrfr8iobo587.pdf
  • Q4 FY2023 Investor Presentation (Mar 2023, PDF): https://www.stockscans.in/document/osh5utdmn750u0jak4siblar.pdf
  • Q3 FY2023 Investor Presentation (Dec 2022, PDF): https://www.stockscans.in/document/p8mfaze9jt0sjba0ik4mydh9.pdf
  • Q2 FY2023 Investor Presentation (Sep 2022, PDF): https://www.stockscans.in/document/iock8e6qiu31kvq4a6gukab4.pdf
  • Q1 FY2023 Investor Presentation (Jun 2022, PDF): https://www.stockscans.in/document/9ni79jtc2lu2ncwap6htxodq.pdf
  • Q4 FY2022 Investor Presentation (Mar 2022, PDF): https://www.stockscans.in/document/x311h76088n5z074k127h7do.pdf
  • Q3 FY2022 Investor Presentation (Dec 2021, PDF): https://www.stockscans.in/document/mhasv5kxmfkqfxv1qfzcis49.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/g0dvdy0y12u2uw802g7kqiyx.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/2dmh7mhp642ixfw0ev6pp60w.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/lzj3stpt3vekufyo4rxve5tl.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/isu7ya6acma7mftg5qol3h0d.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ktoy69dl9s42dey0m4gwj6kj.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ahq8uqxn4j4e13fzfhztyi6p.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/moq5sryxtw6bhjcj184cupw1.pdf